CN1086588C - Pseudomonas active protein and method for producing same - Google Patents
Pseudomonas active protein and method for producing same Download PDFInfo
- Publication number
- CN1086588C CN1086588C CN95119866A CN95119866A CN1086588C CN 1086588 C CN1086588 C CN 1086588C CN 95119866 A CN95119866 A CN 95119866A CN 95119866 A CN95119866 A CN 95119866A CN 1086588 C CN1086588 C CN 1086588C
- Authority
- CN
- China
- Prior art keywords
- pseudomonas
- protein
- mins
- rev
- precipitation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to active pseudomonas protein and a production method thereof. The active pseudomonas protein is composed of protein particles, endotoxin protein, mucus protein and like teichomycin. The production method adopts 11 valence pseudomonas including pseudomonas aeruginosa 1, 2, 3, 4, 5, 6 and 11, serotype standard strains, maltphile olige pseudomonas, pseudomonas putida, pseudomonas stanieri, alkali pseudomonas, and froze and dried standard strain to separate and extract particle protein, ectotoxic toxoid and endotoxin protein (OEP), and utilizes the components (antigenic components) with high immunological activity to synthesize the pseudomonas active protein. The product prevents and cures chronic pulmonary heart disease, pulmonary infection and various pseudomonas infection, represents high efficiency and specificity, and has the advantages of no drug resistance, high safety and no side effect.
Description
Pseudomonas is a kind of low toxicity pathogenic bacterium that see that extensively are present in nature, often be called conditioned pathogen (Opportunisticor conditioned pathogen), susceptible person and its body's immunity to this bacterium lowly have substantial connection, as immunodeficiency, malignant tumor combined chemotherapy patient, use immunosuppressant, tissue transplantation, major operation, urinary system infection, large-area burns etc. and all can merge the infection of this bacterium, often cause septicemia and death.The pseudomonas sickness rate increased to some extent in recent years, because this bacterium has natural bacterial drug resistance, the considerable part bacterial strain produces beta-lactamase, to antibiotics resistance, therefore to the infected or can infectible pseudomonas susceptible person, application specific immunoprophylaxis and treatment replace chemotherapy or are subjected to very big attention now as the ancillary drug of antibiotic therapy, and making specific active immunity with bacterial extract especially is effective best method with prevention infection.
Pseudomonas is that the chronic cardiopulmonary disease pulmonary infection state of an illness increases the weight of and one of cause of death, and by its nosocomial infection that causes and ascendant trend is year by year arranged, mortality rate is up to 50%.In the age of antibiotic high speed development, the M ﹠ M of pseudomonas still is growing on and on, and illustrates that clinical treatment to primary disease still has certain difficulty.Respiratory system Pseudomonas aeruginosa sickness rate accounts for 30～50%, and other pseudomonass account for 40～70%, and antibiosis is have the adaptability of height and drug resistance is the main cause that primary disease infects the long and refractory of duration.Relevant pseudomonas medicine research, the medicine that can be used for treating at present comprises the nearly kind more than 300 of the antibiotic of biological extraction, chemosynthesis, structure of modification, these medicines all have certain curative effect, but pharmacological action can be subjected to multiple factor affecting, and the antibacterial action performance of medicine is restricted.
The object of the present invention is to provide the specificity control medicine of a kind of anti-pseudomonas, and can thoroughly solve pseudomonas active protein and production method thereof prevention of pulmonary heart disease pseudomonas and treatment.
Constituent of the present invention and each components in proportions (weight ratio) are: particulate protein 40%, endotoxin protein 20%, mucus protein 20%, toxoid 20%.Its production method is: take 20 hours liquid cultures of 11 kinds of different pseudomonas third generations respectively, 12000 rev/mins of 4 ℃ of continuous centrifugals are got precipitation, use 0.1M TrisHcl, pH7.2,1mM EDTA give a baby a bath on the third day after its birth time, reuse aforesaid liquid dissolution precipitation thing adds freshly prepared lysozyme＜antalzyme activity in ice bath〉25000), shake up gently, under zero degree, act on 20～30 minutes, this bacteria suspension is put-30 ℃, multigelation three times, make the complete cracking of thalline, with the outstanding mill of colloid mill secondary, each 10 minutes, 4 ℃ centrifugal, 3000 rev/mins, 30 minutes, abandon precipitation (thalline residue), get supernatant, add 5% aluminium potassium sulfate, put 4 ℃ and spend the night, take out next day, 4 ℃ centrifugal, 5000 rev/mins, 30 minutes, get precipitation, be suspended from the middle room temperature dialysis of pH7.2 phosphate buffer (PBS) 24 hours, get dialysate---particulate protein.
With the supernatant of above-mentioned third generation culture after centrifugal, with the aseptic filtration of Cai Sishi funnel, get filtrate and add 5% potassium thiocyanate, the limit edged stirs, and room temperature left standstill 2 hours, transferred to pH3.0 with 1N hydrochloric acid, putting 4 ℃ spends the night, take out next day, and 4 ℃ centrifugal, 12000 rev/mins, get precipitation, the 95% dissolve with ethanol precipitate that adds 0.03N-NaOH, 35 ℃ leave standstill 16 hours (fatty acid in the endotoxin is removed, and make the endotoxin detoxification), transposition is in PBS pH6.8,4 ℃ of low temperature dialysis 24 hours (sample and dialysis solution ratio are 1: 50) change water three times continuously, and it is standby to put 4 ℃ of refrigerators---endotoxin protein (OEP).
Get 24 hours liquid cultures of the pseudomonas third generation, 15000 rev/mins, 4 ℃ of continuous centrifugals, abandon precipitation and get supernatant,, collect filtrate with the acetate fiber membrane filtration of 0.3um, put freezer and be refrigerated to 1-2 ℃, add potassium thiocyanate (first wiring solution-forming), the limit edged stirs, transfer to pH3.0 with 1N hydrochloric acid, put 4 ℃ of iceboxs and spend the night, 12000 rev/mins, 4 ℃ of continuous centrifugals, abandon supernatant, get precipitation, add pre-cooling 95% ethanol, fully the dissolution precipitation thing, 4 ℃ centrifugal 3000 rev/mins, abandon precipitation and get supernatant, transfer to pH5.5 with 0.1N NaOH, 4 ℃ centrifugal, 3000 rev/mins, 30 minutes, abandon supernatant, get precipitation, put PBS pH6.8,4 ℃ of dialysis 24 hours (sample and PBS ratio are 1: 100)---mucus proteins.
Get 24 hours liquid cultures of the pseudomonas third generation, 15000 rev/mins, 4 ℃ of continuous centrifugals, abandon precipitation and get supernatant, add the aseptic filtration of filter paper plate, collect filtrate with the Cai Shi funnel, add 5% potassium thiocyanate, the limit edged stirs, and transfers to pH3.0 with 1N hydrochloric acid, putting 4 ℃ of iceboxs spends the night, take out, 12000 rev/mins, 4 ℃ of continuous centrifugals, add pre-cooling 95% ethanol, fully the dissolution precipitation thing transfers to pH7.8 with 0.1N NaOH, and 4 ℃ centrifugal, 5000 rev/mins 30 minutes, abandon supernatant, get precipitation, place 0.1M TrisHcl buffer (pH8.0) dialysis that contains 4% formalin and 0.3M L-lysine, in 37 ℃ of dialysis detoxification in 4 days, again in pH8.0, in the 0.1MTrisHcl buffer, 24 hours (changing liquid three times) of 4 ℃ of dialysis, to remove formalin, get dialysate---ectotoxic toxoid.
Below in conjunction with embodiment the present invention is described in detail.
Take out 20 liters of 20 hours liquid cultures of 11 kinds of different pseudomonas third generations respectively, 12000 rev/mins of 4 ℃ of continuous centrifugals are got precipitation, use 0.1M TrisHcl, pH7.2,1mM EDTA give a baby a bath on the third day after its birth time, reuse aforesaid liquid 1000ml dissolution precipitation thing adds freshly prepared lysozyme 800～1000mg＜antalzyme activity in ice bath〉25000), shake up gently, under zero degree, act on 20～30 minutes, this bacteria suspension is put-30 ℃, multigelation three times, make the complete cracking of thalline, with the outstanding mill of colloid mill secondary, each 10 minutes, 4 ℃ centrifugal, 3000 rev/mins, 30 minutes, abandon precipitation (thalline residue), get supernatant, add 5% aluminium potassium sulfate 100ml, put 4 ℃ and spend the night, take out next day, 4 ℃ centrifugal, 5000 rev/mins, 30 minutes, get precipitation, be suspended from the middle room temperature dialysis of pH7.2 phosphate buffer (PBS) 24 hours, get dialysate---particulate protein.Get particulate protein 1200mg.
With the supernatant of above-mentioned third generation culture after centrifugal, with the aseptic filtration of Cai Sishi funnel, get filtrate and add 5% potassium thiocyanate 2000ml, the limit edged stirs, and room temperature left standstill 2 hours, transfer to pH3.0 with 1N hydrochloric acid, put 4 ℃ and spend the night, take out next day, and 4 ℃ centrifugal, 12000 rev/mins, get precipitation, add the 95% ethanol 600ml dissolution precipitation thing of 0.03N-NaOH, 35 ℃ leave standstill and (fatty acid in the endotoxin were removed in 16 hours, and make the endotoxin detoxification), transposition is in PBS pH6.8, and 4 ℃ of low temperature dialysis 24 hours (sample and dialysis solution ratio are 1: 50) change water three times continuously, it is standby to put 4 ℃ of refrigerators---and endotoxin protein (OEP) gets endotoxin protein 760mg.
Get 20 liters of 24 hours liquid cultures of the pseudomonas third generation, 15000 rev/mins, 4 ℃ of continuous centrifugals, abandon precipitation and get supernatant,, collect filtrate with the acetate fiber membrane filtration of 0.3um, put freezer and be refrigerated to 1-2 ℃, add potassium thiocyanate (first wiring solution-forming), the limit edged stirs, transfer to pH3.0 with 1N hydrochloric acid, put 4 ℃ of iceboxs and spend the night, 12000 rev/mins, 4 ℃ of continuous centrifugals, abandon supernatant, get precipitation, add pre-cooling 95% ethanol 1000ml, fully the dissolution precipitation thing, 4 ℃ centrifugal 3000 rev/mins, abandon precipitation and get supernatant, transfer to pH5.5 with 0.1N NaOH, 4 ℃ centrifugal, 3000 rev/mins, 30 minutes, abandon supernatant, get precipitation, put PBS pH6.8,4 ℃ of dialysis 24 hours (sample and PBS ratio are 1: 100)---mucus proteins.Get mucus protein 1030mg.
Get 20 liters of 24 hours liquid cultures of the pseudomonas third generation, 15000 rev/mins, 4 ℃ of continuous centrifugals, abandon precipitation and get supernatant, add the aseptic filtration of filter paper plate, collect filtrate with the Cai Shi funnel, add 5% potassium thiocyanate 1850ml, the limit edged stirs, and transfers to pH3.0 with 1N hydrochloric acid, putting 4 ℃ of iceboxs spends the night, take out, 12000 rev/mins, 4 ℃ of continuous centrifugals, add pre-cooling 95% ethanol 1000ml, fully the dissolution precipitation thing transfers to pH7.8 with 0.1N NaOH, and 4 ℃ centrifugal, 5000 rev/mins 30 minutes, abandon supernatant, get precipitation, place 0.1M TrisHcl buffer (pH8.0) dialysis that contains 4% formalin and 0.3M L-lysine, in 37 ℃ of dialysis detoxification in 4 days, again in pH8.0, in the 0.1M TrisHcl buffer, 24 hours (changing liquid three times) of 4 ℃ of dialysis, to remove formalin, get dialysate---ectotoxic toxoid.Get ectotoxic toxoid 812mg.
The pseudomonas active protein portfolio ratio that this method makes: particulate protein 0.4gm, endotoxin protein 0.2gm, mucus protein 0.2gm, toxoid 0.2gm.The merging back is distributed into 1mg/ml with PBS 1000ml (pH6.8) dilution or 2mg/ml supplies subcutaneous or intramuscular injection.
The invention is not restricted to an above-mentioned embodiment.
Use this product and prevent and treat pulmonary heart disease pulmonary and various pseudomonas infection, the Active immunity effect is very desirable, demonstrates efficient and specificity, and the activated protein good stability is taken repeatedly and had no drug resistance, and is safe in utilization, has no side effect.
Claims (2)
1, a kind of pseudomonas active protein, the constituent and each components in proportions (weight ratio) that it is characterized by it are: particulate protein 40%, endotoxin protein 20%, mucus protein 20%, toxoid 20%.
2, a kind of production method of pseudomonas active protein is characterized by:
A. take 20 hours liquid cultures of 11 kinds of different pseudomonas third generations respectively, 12000 rev/mins of 4 ℃ of continuous centrifugals are got precipitation, use 0.1M TrisHcl, pH7.2,1mM EDTA give a baby a bath on the third day after its birth time, reuse aforesaid liquid dissolution precipitation thing, the freshly prepared antalzyme activity of adding is 25000 lysozyme in ice bath, shakes up gently, under zero degree, act on 20～30 minutes, this bacteria suspension is put-30 ℃, multigelation three times, make the complete cracking of thalline, with the outstanding mill of colloid mill secondary, each 10 minutes, 4 ℃ centrifugal, 3000 rev/mins, 30 minutes, abandon precipitation, get supernatant, add 5% aluminium potassium sulfate, put 4 ℃ and spend the night, take out next day, 4 ℃ centrifugal, 5000 rev/mins, 30 minutes, get precipitation, be suspended from the pH7.2 phosphate buffer room temperature dialysis 24 hours, get dialysate---particulate protein;
B. use the supernatant of above-mentioned third generation culture after centrifugal, with the aseptic filtration of Cai Sishi funnel, to get filtrate and add 5% potassium thiocyanate, the limit edged stirs, room temperature left standstill 2 hours, transfer to pH3.0 with 1N hydrochloric acid, put 4 ℃ and spend the night, take out next day, 4 ℃ centrifugal, 12000 rev/mins, get precipitation, add the 95% dissolve with ethanol precipitate of 0.03N-NaOH, 35 ℃ left standstill 16 hours, fatty acid in the endotoxin is removed, and make the endotoxin detoxification, transposition is in PBS pH6.8,4 ℃ of low temperature dialysis 24 hours, sample and dialysis solution ratio are 1: 50, change water continuously three times, and it is standby to put 4 ℃ of refrigerators---endotoxin protein;
C. get 24 hours liquid cultures of the pseudomonas third generation, 15000 rev/mins, 4 ℃ of continuous centrifugals, abandon precipitation and get supernatant,, collect filtrate with the acetate fiber membrane filtration of 0.3um, put freezer and be refrigerated to 1-2 ℃, add the potassium thiocyanate of first wiring solution-forming, the limit edged stirs, transfer to pH3.0 with 1N hydrochloric acid, put 4 ℃ of iceboxs and spend the night 12000 rev/mins, 4 ℃ of continuous centrifugals, abandon supernatant, get precipitation, add pre-cooling 95% ethanol, abundant dissolution precipitation thing, 4 ℃ centrifugal 3000 rev/mins, abandon precipitation and get supernatant, transfer to pH5.5 with 0.1N NaOH, 4 ℃ centrifugal, 3000 rev/mins, 30 minutes, abandon supernatant, get precipitation, put phosphate buffer pH6.8, dialysed 24 hours for 4 ℃, sample and phosphate-buffered liquid proportional are 1: 100---mucus protein;
D. get 24 hours liquid cultures of the pseudomonas third generation, 15000 rev/mins, 4 ℃ of continuous centrifugals, abandon precipitation and get supernatant, add the aseptic filtration of filter paper plate, collect filtrate with the Cai Shi funnel, add 5% potassium thiocyanate, the limit edged stirs, and transfers to PH3.0 with 1N hydrochloric acid, put 4 ℃ of iceboxs and spend the night, take out 12000 rev/mins, 4 ℃ of continuous centrifugals, add pre-cooling 95% ethanol, fully the dissolution precipitation thing transfers to pH7.8 with 0.1N NaOH, 4 ℃ centrifugal, 5000 rev/mins 30 minutes, abandon supernatant, get precipitation, place the 0.1M TrisHcl buffer of the pH8.0 that contains 4% formalin and 0.3M L-lysine to dialyse, in 37 ℃ of dialysis detoxification in 4 days, again in pH8.0, in the 0.1M TrisHcl buffer, dialysed 24 hours for 4 ℃, change liquid three times,, get dialysate to remove formalin---ectotoxic toxoid;
E. merge by a certain percentage by pseudomonas particulate protein, mucus protein, endotoxin protein, ectotoxic toxoid, form pseudomonas active protein.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95119866A CN1086588C (en) | 1995-12-07 | 1995-12-07 | Pseudomonas active protein and method for producing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95119866A CN1086588C (en) | 1995-12-07 | 1995-12-07 | Pseudomonas active protein and method for producing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1184674A CN1184674A (en) | 1998-06-17 |
| CN1086588C true CN1086588C (en) | 2002-06-26 |
Family
ID=5082201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95119866A Expired - Fee Related CN1086588C (en) | 1995-12-07 | 1995-12-07 | Pseudomonas active protein and method for producing same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1086588C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105695539A (en) * | 2016-03-18 | 2016-06-22 | 辽宁成大生物股份有限公司 | Method for inactivating bacterium exotoxin antigen |
| CN109401992B (en) * | 2017-08-18 | 2021-07-23 | 黑龙江省科学院微生物研究所 | Pseudomonas aeruginosa for high-yield endotoxin protein and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0200344A2 (en) * | 1985-03-28 | 1986-11-05 | Mycogen Corporation | Microorganisms as pesticides |
| US5182206A (en) * | 1989-06-27 | 1993-01-26 | House Food Industrial Co., Ltd. | Pyrimine-producing bacteria |
| CN1112356A (en) * | 1993-06-07 | 1995-11-22 | 第一制糖株式会社 | Novel attenuated pseudomonas aeruginosa strains |
-
1995
- 1995-12-07 CN CN95119866A patent/CN1086588C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0200344A2 (en) * | 1985-03-28 | 1986-11-05 | Mycogen Corporation | Microorganisms as pesticides |
| US5182206A (en) * | 1989-06-27 | 1993-01-26 | House Food Industrial Co., Ltd. | Pyrimine-producing bacteria |
| CN1112356A (en) * | 1993-06-07 | 1995-11-22 | 第一制糖株式会社 | Novel attenuated pseudomonas aeruginosa strains |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1184674A (en) | 1998-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chanishvili | Bacteriophages as therapeutic and prophylactic means: summary of the Soviet and post Soviet experiences | |
| Finland et al. | Treatment of pneumococcic meningitis: a study of ten cases treated with sulfanilamide alone or in various combinations with specific antipneumococcic serum and complement, including six recoveries | |
| Feigin et al. | Septic arthritis due to Moraxella osloensis | |
| US20220267419A1 (en) | Human Immunoglobulin Against Methicillin-Resistant Staphylococcus Aureus, Preparation Method Therefor, And Use Thereof | |
| CN1086588C (en) | Pseudomonas active protein and method for producing same | |
| CA2042032C (en) | Therapeutic agent and method of inhibiting vascularization of tumors | |
| Wang et al. | Two cases of pyomyositis caused by Klebsiella pneumoniae and review of the literature | |
| Gradon et al. | Aerosolized vancomycin therapy facilitating nursing home placement | |
| Ormerod et al. | Immune deficiency and multiple viral warts: a possible variant of the Wiskott‐Aldrich syndrome | |
| Wilson et al. | Loss of split thickness skin grafts due to non-group A beta-haemolytic streptococci. | |
| Turner | Acute Laryngotracheitis | |
| Elston et al. | Arm abscesses caused by Clostridium botulinum | |
| Horne et al. | Candida endophthalmitis | |
| WO2020139308A1 (en) | Inactivated staphylococcal liquid vaccine | |
| Karelitz | Choice of an antibiotic: An interpretative review | |
| Mostafavi et al. | Production of soluble virulence factor by Escherichia coli | |
| EP0100366A1 (en) | Agent for treating allergic disease, immunity complex disease, and tumour | |
| Macia et al. | Neisseria mucosa peritonitis in CAPD: another case of the" nonpathogenic" Neisseriae infection | |
| Austin et al. | Fulminant gonococcemia after splenectomy. | |
| Goudie et al. | Subacute Bacterial Endocarditis Due to H. Para-influenzae and Str. Viridans | |
| Wong et al. | The pathogenicity of coagulase negative staphylococcus in the presence of silicone rubber implants | |
| EP0982037A1 (en) | Preventives and/or remedies for sepsis | |
| CN1052160C (en) | Medicinal liquor for curing kidney and urinary system disease and its preparation method | |
| Evans | THE REACTION OF THE SPLEEN IN ACUTE INFECTIONS. | |
| Nicholls | Penicillin in leptospirosis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |